ADP-022

N/A

Report date: 2025/08/01 16:03:01

Base Information

Drug NameADP-022

Drug Alias NameADP-022

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsCheckpoint kinase modulators

TargetsCheckpoint kinase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAlector Inc

China Registration ClassN/A

Active CompaniesAlector Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A